Showing results (161-170 of 582) with videos related to
Sort By:
Pageof 59
Clinical Colorectal Cancer|August 23, 2011
Nonsurgical management of esophageal adenocarcinomaDorothy M Gujral, Maria A Hawkins, Barbara Grilli Leonulli, et al.Frontiers in Pharmacology|November 9, 2023
Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trialsYuxiao Li, Jingya Yang, Chi Ian Chau, et al.Therapeutic Advances in Medical Oncology|March 2, 2016
Efficacy and toxicity of salvage weekly paclitaxel chemotherapy in non-Asian patients with advanced oesophagogastric adenocarcinomaNoelia Tarazona, Elizabeth C Smyth, Clare Peckit, et al.The American Journal of Psychiatry|November 27, 2002
Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosisJonathan Rabinowitz, Goedele De Smedt, Philip D Harvey, et al.Journal of Food Protection|December 17, 2005
Growth inhibition of Escherichia coli O157:H7 and Listeria monocytogenes by carvacrol and eugenol encapsulated in surfactant micellesSylvia Gaysinsky, P Michael Davidson, Barry D Bruce, et al.Journal of Food Science|August 21, 2010
Development of associations and kinetic models for microbiological data to be used in comprehensive food safety prediction softwareAmit Halder, D Glenn Black, P Michael Davidson, et al.Food Microbiology|August 2, 2012
Effectiveness of chitosan on the inactivation of enteric viral surrogatesRobert Davis, Svetlana Zivanovic, Doris H D'Souza, et al.International Journal of Food Microbiology|January 27, 2009
Inactivation of Escherichia coli and Listeria innocua in apple and carrot juices using high pressure homogenization and nisinPanchalee Pathanibul, T Matthew Taylor, P Michael Davidson, et al.Applied and Environmental Microbiology|February 19, 2017
Critical Concentration of Lecithin Enhances the Antimicrobial Activity of Eugenol against Escherichia coliHaoshu Zhang, Edward G Dudley, P Michael Davidson, et al.The Journal of Clinical Psychiatry|October 13, 2012
Bl-1020, a new γ-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety studyYona Geffen, Richard Keefe, Jonathan Rabinowitz, et al.Pageof 59